City council will be asked to support a funding application to the Ontario government to establish a Homelessness and ...

The US Food and Drug Administration has approved Cobenfy, which is owned by pharmaceutical firm Bristol Myers Squibb.

However, in the wake of increasing national attention on mental health, the average person's understanding of the topic is ...

The US Food and Drug Administration has greenlit a new drug, marketed as Cobenfy, for oral use to treat schizophrenia in ...

· Health premium costs were 3.4 percent lower for individual coverage plans for companies in medical cannabis states compared ...

Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades.

The Drug program (Designing Reachable United Goals) started 21 months ago and is at capacity with 26 participants — 18 men and eight women. Stephanie Beechler of Springfield has been in the program ...

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel ...

A clear provincewide consensus on specific matters related to addiction and treatment has emerged, weeks ahead of the 2024 ...

The Hall-Perrine Foundation has announced a $1 million matching grant to support the St. Luke’s Foundation for UnityPoint ...

The Chester County Reentry Coalition hosted a Reentry Simulation – an exercise where participants walk in the shoes of ...

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...